At the same time, Christina et al. revealed that G0S2 acts as a tumor suppressor in breast cancer by regulating PI3K/mTOR activity, and G0S2 improves therapeutic responses to PI3K/mTOR inhibitors (Yim et al. 2017). This evidence concerns the gene MTOR and breast cancer.